All In Biotech

Drug Trial Radar · NCT02901184

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF

Last checked: Nov 20, 2026Latest source record: Oct 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Nov 23, 2017

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Uppsala UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Karolinska University; Duke Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
First posted
Sep 15, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) suggest spironolactone may be effective in HFPEF, but it is generic and will not be studied by industry. SPIRRIT is a unique Registry-Randomized Clinical Trial (RRCT) that will test the hypothesis that spironolactone plus standard of care compared to standard of care alone reduces the composite of CV mortality and HF hospitalization as follows: Population: HFPEF patients in the Swedish Heart Failure Registry and HFPEF patients in US. HFPEF defined as symptoms/signs of HF, elevated NTproBNP (B-type Natriuretic Peptide; N-terminal pro b-type Natriuretic Peptide) and EF\>=40%. Intervention and control: Randomized 1:1 to intervention: spironolactone + usual care vs. control: usual care alone. Outcome: Primary outcome cardiovascular death or time to HF hospitalization. Secondary outcomes include hospitalization for various causes, adverse events and treatment adherence. In Sweden outcomes are obtained automatically by linking with the Population, Patient and Drug Dispensed Registries. In the US, outcomes will be reported by sites and supplemented by data from a call center. The trial is event-driven with enrollment 7 years and study duration 9 years. For the primary outcome (CV Death or first HF hospitalization) with an event target of 721 events the sample size requires 1985 patients conservatively rounded to approximately 2000 patients.

Conditions

  • Heart Failure With Preserved Ejection Fraction

Interventions

  • SpironolactoneDrug

    Treatment with Spironolactone tablets on top of standard care

  • Standard careOther

    Standard care does not involve Spironolactone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence rate for total heart failure (HF) hospitalizations or cardiovascular (CV) deathTime frame: Collected at data base lock, five (5) years after study start (US: continuously until 5 years after study start)

Locations

78 sites in 2 countries. Site status is shown where the registry gives one.

  • Advanced Cardiovascular LLC

    Alexander City, Alabama · Terminated

  • University of Alabama at Birmingham

    Birmingham, Alabama · Terminated

  • Banner - University Medical Group

    Tucson, Arizona · Terminated

  • MedStar Cardiovascular Research Network

    Washington D.C., District of Columbia · Terminated

  • Howard University Hospital

    Washington D.C., District of Columbia · Terminated

  • Holy Cross Hospital

    Fort Lauderdale, Florida · Terminated

  • Piedmont Atlanta Hospital

    Atlanta, Georgia · Terminated

  • Wellstar Health System, Inc.

    Marietta, Georgia · Terminated

  • Queens Medical Center

    Honolulu, Hawaii · Terminated

  • Fox Valley Clinical Research Center, LLC

    Aurora, Illinois · Terminated

  • University of Illinois at Chicago

    Chicago, Illinois · Terminated

  • Alexian Brothers Medical Center

    Elk Grove Village, Illinois · Terminated

  • Methodist Medical Center of Illinois

    Peoria, Illinois · Terminated

  • St. Vincent Medical Group

    Indianapolis, Indiana · Terminated

  • Ochsner Medical Center

    New Orleans, Louisiana · Terminated

  • Shady Grove Adventist Hospital

    Rockville, Maryland · Terminated

  • Brigham and Women's Hospital

    Boston, Massachusetts · Terminated

  • Pentucket Medical Associates

    Haverhill, Massachusetts · Terminated

  • Charles River Medical Associates

    Natick, Massachusetts · Terminated

  • Newton-Wellesley Hospital

    Newton, Massachusetts · Terminated

  • University of Michigan Medical Center

    Ann Arbor, Michigan · Terminated

  • Ascension Genesys Hospital

    Grand Blanc, Michigan · Terminated

  • The Heart House Haddon Heights

    Haddon Heights, New Jersey · Terminated

  • Rutgers University - Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Terminated

  • University of New Mexico Health Science Center

    Albuquerque, New Mexico · Terminated

  • University at Buffalo

    Buffalo, New York · Terminated

  • Northwell Health - Manhasset

    Manhasset, New York · Terminated

  • Mount Sinai Medical Cente

    New York, New York · Terminated

  • Mid Carolina Cardiology Research

    Charlotte, North Carolina · Terminated

  • Duke University

    Durham, North Carolina · Terminated

  • University of Cincinnati Medical Center

    Cincinnati, Ohio · Terminated

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania · Terminated

  • Jefferson University Hospital

    Philadelphia, Pennsylvania · Terminated

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania · Terminated

  • Stern Cardiovascular Center

    Germantown, Tennessee · Terminated

  • Baylor University Medical Center

    Dallas, Texas · Terminated

  • University of Miami Hospital

    Miami, Texas · Terminated

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas · Terminated

  • Hälsostaden Ängelholms sjukhus

    Ängelholm, Sweden · Terminated

  • Angereds närsjukhus

    Angered, Sweden · Terminated

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.